secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRISTOL MYERS SQUIBB CO (BMY)
CIK:        0000014272
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0000014272-25-000129
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BMY Q2 revenue $12.3B, GAAP EPS $0.64, non-GAAP EPS $1.46; raises revenue guidance
--------------------------------------------------------------------------------

- Revenue $12.3B, +1% YoY; Growth Portfolio $6.6B, +18% YoY (+17% ex-FX).
- GAAP EPS $0.64 vs $0.83 YoY; non-GAAP EPS $1.46 vs $2.07 YoY, both hit by $(0.57) BioNTech IPRD charge.
- 2025 revenue guidance raised to ~$46.5B–$47.5B; non-GAAP EPS guidance updated to $6.35–$6.65.
- BioNTech strategic partnership resulted in a $0.57 per share Acquired IPRD charge in Q2.
- CEO cites strong Growth Portfolio execution, cost optimization, and pipeline partnerships.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/14272/000001427225000129/0000014272-25-000129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/14272/000001427225000129/bmy-20250731.htm
  HTML page:      https://secwatch.observer/filing/0000014272-25-000129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer